Four groups get Longitude funds for point-of-care tests including Sepsis

Four groups get Longitude funds for point-of-care tests | CIDRAP:

The Longitude Prize has named the latest winners of funding for the development of point-of-care diagnostic tests that will conserve antibiotics.

Three teams focus on sepsis

Three of the newly awarded teams are developing tests that could help reduce morbidity and mortality due to sepsis, a condition that occurs when the body's reaction to infection triggers an inflammatory response throughout the body. IDI Group is developing an ultrasensitive magnetic biosensor to rapidly detect and identify endotoxins in the blood, an innovation that could help clinicians treat sepsis in its early stages and choose the right antibiotic therapy.